Jochen Wilke

518 total citations
21 papers, 265 citations indexed

About

Jochen Wilke is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jochen Wilke has authored 21 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Surgery. Recurrent topics in Jochen Wilke's work include Cancer Immunotherapy and Biomarkers (5 papers), Renal cell carcinoma treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Jochen Wilke is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Renal cell carcinoma treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Jochen Wilke collaborates with scholars based in Germany, United States and Switzerland. Jochen Wilke's co-authors include William L. Nichols, Gerald S. Gilchrist, David Dingli, Rajiv K. Pruthi, John A. Heit, D A Gastineau, Bernhard Walter, Albrecht Reichle, T. Suedhoff and Anna Berand and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Stem Cells.

In The Last Decade

Jochen Wilke

17 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jochen Wilke Germany 8 98 77 73 72 56 21 265
Vladimir Gotlieb United States 7 93 0.9× 42 0.5× 53 0.7× 99 1.4× 69 1.2× 31 280
Juan G. Posada Colombia 8 83 0.8× 56 0.7× 15 0.2× 40 0.6× 51 0.9× 22 244
Maria Koumpou Greece 8 139 1.4× 28 0.4× 80 1.1× 146 2.0× 68 1.2× 12 321
Dalyong Kim South Korea 9 92 0.9× 15 0.2× 27 0.4× 102 1.4× 55 1.0× 27 304
Charisios Karanikiotis Greece 9 103 1.1× 18 0.2× 84 1.2× 164 2.3× 22 0.4× 18 308
Marco Rensi Italy 5 101 1.0× 140 1.8× 22 0.3× 19 0.3× 68 1.2× 9 204
Emily Prendergast United States 10 78 0.8× 19 0.2× 109 1.5× 38 0.5× 127 2.3× 29 326
Sandra Beare United Kingdom 9 200 2.0× 18 0.2× 107 1.5× 170 2.4× 102 1.8× 11 372
Maria Teresa Nobile Italy 11 219 2.2× 27 0.4× 17 0.2× 56 0.8× 23 0.4× 22 310

Countries citing papers authored by Jochen Wilke

Since Specialization
Citations

This map shows the geographic impact of Jochen Wilke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Wilke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Wilke more than expected).

Fields of papers citing papers by Jochen Wilke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen Wilke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Wilke. The network helps show where Jochen Wilke may publish in the future.

Co-authorship network of co-authors of Jochen Wilke

This figure shows the co-authorship network connecting the top 25 collaborators of Jochen Wilke. A scholar is included among the top collaborators of Jochen Wilke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jochen Wilke. Jochen Wilke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aigner, Michael, Katharina Zimmermann, Axel Schambach, et al.. (2025). Functional differences between CLL‐ and ALL‐derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL‐10 as potential modulatory targets. HemaSphere. 9(12). e70279–e70279.
2.
Völkl, Simon, David B. Blumenthal, Frederik Graw, et al.. (2025). 3D Tumor microenvironment interaction reveals AP‐1 complex regulation and contact‐mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia. HemaSphere. 9(8). e70199–e70199. 1 indexed citations
3.
Bauer, Marcus, Jochen Wilke, Volker Hanf, et al.. (2024). Prognostic and predictive impact of NOTCH1 in early breast cancer. Breast Cancer Research and Treatment. 209(1). 27–38.
4.
Voelkl, Simon, et al.. (2021). Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia. Leukemia & lymphoma. 62(11). 2679–2689. 3 indexed citations
5.
6.
Fuchs, Maximilian, Meik Kunz, Simon Voelkl, et al.. (2021). Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia. Stem Cells. 39(6). 819–830. 5 indexed citations
7.
8.
Dall, Peter, Thomas Göhler, Christian Lerchenmüller, et al.. (2015). Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany. Journal of Geriatric Oncology. 6(6). 462–469. 19 indexed citations
9.
Walter, Bernhard, Martin Vogelhuber, Jochen Grassinger, et al.. (2011). Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. Medical Oncology. 29(2). 799–805. 25 indexed citations
10.
11.
Moehler, Markus, Tanja Trarbach, T Seufferlein, et al.. (2008). Cetuximab with irinotecan/NA-FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomised multi-centre AIO phase II study. mediaTUM (Technical University of Munich). 8 indexed citations
12.
Stengel, Dirk, Andreas du Bois, Susanne Markmann, et al.. (2007). Topotecan weekly versus routine 5-day schedule in patients with platinum-resistant ovarian cancer (TOWER): A randomized, two-stage phase-II study of the North-Eastern German Society of Gynaecological Oncology (NOGGO). Journal of Clinical Oncology. 25(18_suppl). 5526–5526. 6 indexed citations
13.
Reichle, Albrecht, Jochen Grassinger, K. Bross, et al.. (2007). C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation.. PubMed. 1. 87–98. 16 indexed citations
14.
Reichle, Albrecht, Bernhard Walter, Anna Berand, et al.. (2007). Induction of complete remission in metastatic hormone-refractory prostate cancer: A combined anti-inflammatory therapy approach. Journal of Clinical Oncology. 25(18_suppl). 15636–15636. 1 indexed citations
15.
Wilke, Jochen, et al.. (2006). Chronische Anämie bei hereditärer hämorrhagischer Teleangiektasie und juveniler Polyposis des Magens. DMW - Deutsche Medizinische Wochenschrift. 131(33). 1803–1806. 4 indexed citations
16.
Reichle, Albrecht, Jochen Grassinger, K. Bross, et al.. (2006). Effect of anti-inflammatory therapy in patients with metastatic renal cell carcinoma on clinical response. Journal of Clinical Oncology. 24(18_suppl). 14500–14500.
17.
Reichle, Albrecht, Jochen Grassinger, K. Bross, et al.. (2006). C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation. Biomarker Insights. 1. 2137016740–2137016740. 7 indexed citations
18.
19.
Gilchrist, Gerald S., et al.. (2001). Intrauterine correction of factor VIII (FVIII) deficiency. Haemophilia. 7(5). 497–499. 7 indexed citations
20.
Pruthi, Rajiv K., et al.. (2000). Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden). Haemophilia. 6(6). 631–634. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vladimir Gotlieb Breakdown of academic impact, for papers by Juan G. Posada Breakdown of academic impact, for papers by Maria Koumpou Breakdown of academic impact, for papers by Dalyong Kim Breakdown of academic impact, for papers by Charisios Karanikiotis Breakdown of academic impact, for papers by Marco Rensi Breakdown of academic impact, for papers by Emily Prendergast Breakdown of academic impact, for papers by Sandra Beare Breakdown of academic impact, for papers by Maria Teresa Nobile
Rankless by CCL
2026